Complementary use of peritoneal and hemodialysis: Therapeutic synergies in the treatment of end-stage renal failure patients

Kidney International

Volumn 73, Issue SUPPL. 108, 2008, Pages

  Kawanishi, H ^a   McIntyre, C ^b,c  

^a TSUCHIYA GENERAL HOSPITAL   (Japan)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c DERBY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Bimodal dialysis; Dialysis adequacy; Hemodialysis; Peritoneal dialysis; Ultrafiltration failure

Indexed keywords

BLOOD VESSEL CALCIFICATION; CLINICAL PRACTICE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; HEART EJECTION FRACTION; HEART INJURY; HEMODIALYSIS; HUMAN; KIDNEY CLEARANCE; KIDNEY FAILURE; KIDNEY FUNCTION; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; SHORT SURVEY; ULTRAFILTRATION; CHRONIC KIDNEY FAILURE; MULTIMODALITY CANCER THERAPY; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY; REVIEW;

COMBINED MODALITY THERAPY; HUMANS; KIDNEY FAILURE, CHRONIC; NUTRITIONAL STATUS; PERITONEAL DIALYSIS; RENAL DIALYSIS; ULTRAFILTRATION;

EID: 44449139159     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002603     Document Type: Article

References (31)

1. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9(Suppl): S16-S23.
2. Hocher B, Ziebig R, Altermann C et al. Different impact of biomarkers as mortality predictors among diabetic and nondiabetic patients undergoing hemodialysis. J Am Soc Nephrol 2003; 14: 2329-2337.
3. London GM, Parfrey PS. Cardiac disease in chronic uremia: pathogenesis. Adv Ren Replace Ther 1997; 4: 194-211.
4. Guerin AP, Adda H, London GM, Marchais SJ. Cardiovascular disease in renal failure. Minerva Urol Nefrol 2004; 56: 279-288.
5. Nelson CB, Port FK, Wolfe RA et al. Comparison of continuous ambulatory peritoneal dialysis and hemodialysis patient survival with evaluation of trends during the 1980s. J Am Soc Nephrol 1992; 3: 1147-1155.
6. Held PJ, Port FK, Turenne MN et al. Continuous ambulatory peritoneal dialysis and hemodialysis: Comparison of patient mortality with adjustment for comorbid conditions. Kidney Int 1994; 45: 1163-1169.
7. Fenton SS, Schaubel DE, Desmeules M et al. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis 1997; 30: 334-342.
8. Foley RN, Parfrey PS, Harnett JD et al. Mode of dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol 1998; 9: 267-276.
9. Hebert MJ, Falardeau M, Pichette V et al. Continuous ambulatory peritoneal dialysis for patients with severe left ventricular systolic dysfunction and end-stage renal disease. Am J Kidney Dis 1995; 25: 761-768.
10. Diaz-Buxo JA. Peritoneal dialysis adequacy: a model to assess feasibility with various modalities. Kidney Int 1999; 55: 2493-2501.
11. Kawanishi H, Hashimoto Y, Nakamoto H et al. Combination therapy with peritoneal dialysis and hemodialysis. Perit Dial Int 2006; 26: 150-154.
12. McIntyre CW. Bi-modal dialysis (BMD): an integrated approach to renal replacement therapy. Perit Dial Int 2004; 24: 547-553.
13. Sigrist M, Bungay P, McIntyre CW. Vascular calcification and its attendant cardiovascular consequences: a comparison between CKD 4, peritoneal dialysis and haemodialysis patients. Nephrol Dial Transplant 2006; 21: 707-714.
14. Sigrist MK, Taal MW, McIntyre CW. The determinants and functional consequences of progressive vascular calcification in chronic kidney disease. Clin J Am Soc Nephrol 2007 (in press).
15. Sigrist MK, Dervin L, McIntyre CW. Length of interdialytic interval influences serum calcium and phosphorous concentrations. Nephrol Dialysis Transplant 2005; 20: 1643-1646.
16. Sigrist M, McIntyre CW. Calcium exposure and removal in chronic haemodialysis patients. J Ren Nutr 2006; 16: 41-46.
17. Selby NM, Lambie SH, Baker CSR et al. Dialysis-induced left ventricular dysfunction: a novel mechanism in the development of heart failure in chronic haemodialysis patients. Am J Kidney Dis 2006; 47: 830-841.
18. Selby NJ, Burton JO, McIntyre CW. Dialysis induced regional left ventricular dysfunction is ameliorated by cooling the dialysate. Clin J Am Soc Nephrol 2006; 1: 1216-1225.
19. Burton JO, Korsheed S, McIntyre CW. The prevalence and variability of haemodialysis induced acute myocardial stunning. EDTA 2007: Sap284.
20. McIntyre CW, Burton JO, Selby NJ et al. Haemodialysis induced effects on myocardial blood flow. Clin J Am Soc Nephrol 2007 (in press).
21. Ronco C, Feriani M, Chiaramonte S et al. Impact of high blood flows on vascular stability in haemodialysis. Nephrol Dial Transplant 1990; 5(Suppl 1): S109-S114.
22. Selby NM, Fialova J, Burton JO, McIntyre CW. The haemodynamic and metabolic effects of hypertonic-glucose and amino-acid-based peritoneal dialysis fluids. Nephrol Dial Transplant 2007; 22: 870-879.
23. Selby NM, Fonseca S, Hulme L et al. Automated peritoneal dialysis has significant effects on systemic hemodynamics. Perit Dial Int 2006; 26: 328-335.
24. Selby NM, Fonseca S, Hulme L et al. Hypertonic glucose-based peritoneal dialysate is associated with higher blood pressure and adverse haemodynamics as compared with icodextrin. Nephrol Dial Transplant 2005; 20: 1848-1853.
25. Kawanishi H, Moriishi M, Tsuchiya S. Five years' experience of combination therapy: peritoneal dialysis with hemodialysis. Adv Perit Dial 2002; 18: 62-67.
26. Agarwal M, Clinard P, Burkart JM. Combined peritoneal dialysis and hemodialysis: our experience compared to others. Perit Dial Int 2003; 23: 157-161.
27. Fukui H, Hara S, Hashimoto Y et al. Review of combination of peritoneal dialysis and hemodialysis as a modality of treatment for end-stage renal disease. Ther Apher Dial 2004; 8: 56-61.
28. Davies SJ, Phillips L, Naish PF, Russell GI. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001; 12: 1046-1051.
29. Davies SJ, Brown EA, Frandsen NE et al. Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription. Kidney Int 2005; 67: 1609-1615.
30. Peritoneal Dialysis Adequacy Work Group. Clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis 2006; 48(Suppl 1): S98-S129.
31. Nakamoto H, Imai H, Kawanishi H et al. Effect of diabetes on peritoneal function assessed by personal dialysis capacity test in patients undergoing CAPD. Am J Kidney Dis 2002; 40: 1045-1054.